BioEurope 2026

Meet Arcinova at BioEurope, Germany. Accelerating your programme with integrated CMC excellence. From lab to life.

Arcinova is attending BioEurope in Germany on 9-11 November, 2026, where we’ll be connecting with companies progressing innovative therapies towards the clinic. Early development often involves complex scientific, technical and regulatory decisions. By integrating expertise across the drug development pathway, we help simplify the path forward and reduce risk. Meet with our team to discuss how we can support:

• Building a robust CMC dossier (IMPD/IND) to support clinical trial applications
• Drug Substance – Accelerating API development from route design to GMP supply 
• Drug Product – Progressing candidates rapidly to the clinic through formulation and manufacturing expertise 
• Isotope Labelling – Supporting ADME studies with bespoke radiolabelled compounds
• Bioanalysis – Delivering PK, metabolism and ADME data with confidence
• RNA Development – Advancing oligonucleotide and RNA therapeutics through integrated development and CMC expertise

Book a meeting via the button on this page to discuss how we can support your next programme.